chevron_leftBack
As of 14 June 2026, Yuyu Pharma, Inc. has a market cap of $44.42M USD, ranking #31417 globally and #1830 in South Korea.
It ranks #2845 in the Healthcare sector, and #992 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$44.42MUSD
67.56B KRW
Enterprise Value
$50.24MUSD
76.28B KRW
Revenue (TTM)
$92.64MUSD
140.88B KRW
EBITDA (TTM)
$10.95MUSD
16.63B KRW
Net Income (TTM)
$5.36MUSD
8.15B KRW
EBITDA Margin
12%
Profit Margin
5.8%
PE Ratio
8.9
PS Ratio
0.5
PB Ratio
0.5
EV/EBITDA
4.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Wonsang Yu
open_in_new
Employees
254
Founded
1941
Website
yuyu.co.kr
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.1% | 0.2% | -1.4% | -3.9% | 1.8% | -7.4% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
000220
(주)유유제약
ISIN: KR7000220004
Shares Out.:
Shares Outstanding:
15.748M1
Shares Float:
9.313M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
4,245 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Yuyu Pharma, Inc.
Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.15B
20K%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.77B
15K%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.24B
12K%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.96B
11K%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.55B
10K%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.44B
10K%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
2M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
1M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
812K%
|
97.4
|
|
SIX: RO
|
$321.52B
724K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
650K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
618K%
218.9B CHF
|
20.5
|
chevron_leftBack